Literature DB >> 15047824

Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells.

Karen M Duus1, Vivian Lentchitsky, Timothy Wagenaar, Charles Grose, Jennifer Webster-Cyriaque.   

Abstract

Based on the observation that wild-type Kaposi's sarcoma-associated herpesvirus (KSHV) DNA can be detected in the oral cavity of healthy, immunocompetent individuals, we hypothesized that epithelial cells could be infected in vitro by wild-type (WT) KSHV isolated from immunocompetent individuals. Primary oral epithelial (P-EPI) cells and telomerase-immortalized oral epithelial cells were generated from human gingival tissue and were then infected in vitro with WT KSHV isolated from throat wash samples. Markers of lytic and latent KSHV infection were detected in cultures by 24 h postinfection by immunofluorescence confocal microscopic assays. The infectivity of the WT and BCBL virus was blocked by neutralizing antibodies against KSHV gB. The presence of KSHV DNA in these cells was confirmed by real-time PCR amplification of different regions of the viral genome. The significant in vitro viral replication that had occurred was inhibited by ganciclovir and by neutralizing antibodies against gB. When infected cultures were examined by scanning electron microscopy, thousands of KSHV particles were clearly visible across the surfaces of P-EPI cells. The detection of enveloped particles indicated that the infectious cycle had proceeded through assembly and egress. We thus demonstrated that oral WT KSHV isolated from immunocompetent individuals was able to infect and replicate in vitro in a relevant primary cell type. Furthermore, our results provide compelling evidence for KSHV transmission within infected oral epithelial cells derived from healthy, immunocompetent populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047824      PMCID: PMC374256          DOI: 10.1128/jvi.78.8.4074-4084.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Development of Kaposi's sarcoma in a surgical wound.

Authors:  Jennifer Webster-Cyriaque
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus.

Authors:  K M Duus; E D Miller; J A Smith; G I Kovalev; L Su
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

Authors:  D H Kedes; D Ganem
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men.

Authors:  Corey Casper; Anna Wald; John Pauk; Stephen R Tabet; Lawrence Corey; Connie L Celum
Journal:  J Infect Dis       Date:  2002-03-11       Impact factor: 5.226

5.  Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.

Authors:  S M Akula; N P Pramod; F Z Wang; B Chandran
Journal:  Virology       Date:  2001-06-05       Impact factor: 3.616

6.  Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells.

Authors:  Shaw M Akula; Naranatt P Pramod; Fu Zhang Wang; Bala Chandran
Journal:  Cell       Date:  2002-02-08       Impact factor: 41.582

7.  Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR.

Authors:  Farnaz D Fakhari; Dirk P Dittmer
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.

Authors:  Michael Lagunoff; Jill Bechtel; Eleni Venetsanakos; Anne-Marie Roy; Nancy Abbey; Brian Herndier; Martin McMahon; Don Ganem
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Mixed patterns of transmission of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) in Malawian families.

Authors:  Rachelle D Cook; Tim A Hodgson; Alastair C W Waugh; Elizabeth M Molyneux; Eric Borgstein; A Sherry; Chong Gee Teo; Stephen R Porter
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

10.  Tracking familial transmission of Kaposi's sarcoma-associated herpesvirus using restriction fragment length polymorphism analysis of latent nuclear antigen.

Authors:  R D Cook; T A Hodgson; E M Molyneux; E Borgstein; S R Porter; C G Teo
Journal:  J Virol Methods       Date:  2002-09       Impact factor: 2.014

View more
  35 in total

Review 1.  The role of actin bundling proteins in the assembly of filopodia in epithelial cells.

Authors:  Seema Khurana; Sudeep P George
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

Review 2.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

3.  HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study.

Authors:  C Casper; D Carrell; K G Miller; F D Judson; A S Meier; J S Pauk; R A Morrow; L Corey; A Wald; C Celum
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

Review 4.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Authors:  Don Ganem
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

5.  Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  T L Morris; R R Arnold; J Webster-Cyriaque
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Melanie M Brinkmann; Marcel Pietrek; Oliver Dittrich-Breiholz; Michael Kracht; Thomas F Schulz
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Authors:  Craig S Miller; Joseph R Berger; Yunanan Mootoor; Sergei A Avdiushko; Hua Zhu; Richard J Kryscio
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

8.  Herpesvirus-encoded microRNAs detected in human gingiva alter host cell transcriptome and regulate viral infection.

Authors:  Afsar R Naqvi; Alexandra Seal; Jennifer Shango; Maria F Brambila; Gloria Martinez; Gabriela Chapa; Shirin Hasan; Tejabhiram Yadavalli; Dinesh Jaishankar; Deepak Shukla; Salvador Nares
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-03-15       Impact factor: 4.490

9.  LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Authors:  David C Brice; Zsolt Toth; Gill Diamond
Journal:  Antiviral Res       Date:  2018-08-02       Impact factor: 5.970

10.  X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.

Authors:  Sam J Wilson; Edward H Tsao; Benjamin L J Webb; Hongtao Ye; Lucy Dalton-Griffin; Christoforos Tsantoulas; Catherine V Gale; Ming-Qing Du; Adrian Whitehouse; Paul Kellam
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.